Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Negative pressure wound therapy of Corynebacterium jeikeium associated granulomatous mastitis.

Maráz R, Venczel L, Sikorszki L, Serfőző O, Ambrózay É, Patyi M, Cserni G.

Breast J. 2019 Sep 11. doi: 10.1111/tbj.13573. [Epub ahead of print]

PMID:
31512310
2.

Selective Heart Irradiation Induces Cardiac Overexpression of the Pro-hypertrophic miR-212.

Sárközy M, Gáspár R, Zvara Á, Kiscsatári L, Varga Z, Kővári B, Kovács MG, Szűcs G, Fábián G, Diószegi P, Cserni G, Puskás LG, Thum T, Kahán Z, Csont T, Bátkai S.

Front Oncol. 2019 Jul 16;9:598. doi: 10.3389/fonc.2019.00598. eCollection 2019.

3.

Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.

Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G, Bianchi S, Kaya H, Amendoeira I, Querzoli P, Poli F, Scatena C, Cordoba A, Pietribiasi F, Kovács A, Faistova H, Cserni G, Quinn C.

Eur J Surg Oncol. 2019 Jul 5. pii: S0748-7983(19)30548-7. doi: 10.1016/j.ejso.2019.07.011. [Epub ahead of print]

PMID:
31301938
4.

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.

Tőkés AM, Rusz O, Cserni G, Tóth E, Rubovszky G, Tőkés T, Vízkeleti L, Reiniger L, Kószó R, Kahán Z, Kulka J, Donia M, Vörös A, Szallasi Z.

Acta Oncol. 2019 Jul 4:1-9. doi: 10.1080/0284186X.2019.1633015. [Epub ahead of print]

PMID:
31271119
5.

[Evaluation of resection margins following breast conserving surgery for breast cancer. A multicentric retrospective study].

Fakan B, Baranyi E, Horváth R, Kálmán E, Kulka J, Tölgyesi K, Török M, Udvarhelyi N, Zombori T, Cserni G.

Orv Hetil. 2019 Jun;160(26):1036-1044. doi: 10.1556/650.2019.31449. Hungarian.

PMID:
31230468
6.

Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.

Sávolt Á, Cserni G, Lázár G, Maráz R, Kelemen P, Kovács E, Győrffy B, Udvarhelyi N, Vörös A, Ormándi K, Mátrai Z.

Eur J Surg Oncol. 2019 May 16. pii: S0748-7983(19)30454-8. doi: 10.1016/j.ejso.2019.05.016. [Epub ahead of print]

PMID:
31126680
7.

Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Kulka J, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2019 Mar 30. pii: mdz081. doi: 10.1093/annonc/mdz081. [Epub ahead of print] No abstract available.

8.

Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.

Sárközy M, Gáspár R, Zvara Á, Siska A, Kővári B, Szűcs G, Márványkövi F, Kovács MG, Diószegi P, Bodai L, Zsindely N, Pipicz M, Gömöri K, Kiss K, Bencsik P, Cserni G, Puskás LG, Földesi I, Thum T, Bátkai S, Csont T.

Sci Rep. 2019 Feb 4;9(1):1302. doi: 10.1038/s41598-018-37690-5.

9.

Patterns of Regression in Breast Cancer after Primary Systemic Treatment.

Zombori T, Cserni G.

Pathol Oncol Res. 2019 Jul;25(3):1153-1161. doi: 10.1007/s12253-018-0557-7. Epub 2018 Nov 27.

PMID:
30484262
10.

Apocrine Encapsulated Papillary Carcinoma of the Breast: The First Reported Case with an Infiltrative Component.

Kővári B, Ormándi K, Simonka Z, Vörös A, Cserni G.

J Breast Cancer. 2018 Jun;21(2):227-230. doi: 10.4048/jbc.2018.21.2.227. Epub 2018 Jun 20.

11.

Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.

Coulson-Gilmer C, Humphries MP, Sundara Rajan S, Droop A, Jackson S, Condon A, Cserni G, Jordan LB, Jones LJ, Kanthan R, Di Benedetto A, Mottolese M, Provenzano E, Kulka J, Shaaban AM, Hanby AM, Speirs V.

J Pathol Clin Res. 2018 Oct;4(4):241-249. doi: 10.1002/cjp2.106. Epub 2018 Aug 23. Erratum in: J Pathol Clin Res. 2019 Jul;5(3):213.

12.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2018 Sep 1;29(9):1948-1954. doi: 10.1093/annonc/mdy216. Erratum in: Ann Oncol. 2019 Mar 30;:.

13.

Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.

Kővári B, Kocsis L, Varga E, Cserni G.

Pol J Pathol. 2018;69(1):48-52. doi: 10.5114/pjp.2018.75336.

14.

Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.

O'Loughlin M, Andreu X, Bianchi S, Chemielik E, Cordoba A, Cserni G, Figueiredo P, Floris G, Foschini MP, Heikkilä P, Kulka J, Liepniece-Karele I, Regitnig P, Reiner A, Ryska A, Sapino A, Shalaby A, Stovgaard ES, Quinn C, Walsh EM, Zolota V, Glynn SA, Callagy G.

Breast Cancer Res Treat. 2018 Aug;171(1):1-9. doi: 10.1007/s10549-018-4825-8. Epub 2018 May 17.

PMID:
29774470
15.

Inflammatory breast cancer: The pathologists' perspective.

Cserni G, Charafe-Jauffret E, van Diest PJ.

Eur J Surg Oncol. 2018 Aug;44(8):1128-1134. doi: 10.1016/j.ejso.2018.04.001. Epub 2018 Apr 18. Review.

PMID:
29706301
16.

The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.

Zombori T, Nyári T, Tiszlavicz L, Pálföldi R, Csada E, Géczi T, Ottlakán A, Pécsy B, Cserni G, Furák J.

Virchows Arch. 2018 Jun;472(6):949-958. doi: 10.1007/s00428-018-2337-x. Epub 2018 Apr 2.

PMID:
29611055
17.

Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Lozada JR, Basili T, Pareja F, Alemar B, Paula ADC, Gularte-Merida R, Giri DD, Querzoli P, Cserni G, Rakha EA, Foschini MP, Reis-Filho JS, Brogi E, Weigelt B, Geyer FC.

Histopathology. 2018 Aug;73(2):339-344. doi: 10.1111/his.13522. Epub 2018 Jun 1.

PMID:
29603332
18.

Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium.

Cserni G.

Virchows Arch. 2018 Aug;473(2):145-153. doi: 10.1007/s00428-018-2343-z. Epub 2018 Mar 28.

PMID:
29594352
19.

The new TNM-based staging of breast cancer.

Cserni G, Chmielik E, Cserni B, Tot T.

Virchows Arch. 2018 May;472(5):697-703. doi: 10.1007/s00428-018-2301-9. Epub 2018 Jan 27. Review.

PMID:
29380126
20.

Elastic stains in the evaluation of DCIS with comedo necrosis in breast cancers.

Zombori T, Cserni G.

Virchows Arch. 2018 Jun;472(6):1007-1014. doi: 10.1007/s00428-017-2259-z. Epub 2017 Nov 3.

PMID:
29101458
21.
22.

The role of preoperative axillary ultrasound and fine-needle aspiration cytology in identifying patients with extensive axillary lymph node involvement.

Maráz R, Zombori T, Ambrózay É, Cserni G.

Eur J Surg Oncol. 2017 Nov;43(11):2021-2028. doi: 10.1016/j.ejso.2017.08.007. Epub 2017 Aug 30.

PMID:
28919032
23.
24.

Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.

Zombori T, Furák J, Nyári T, Cserni G, Tiszlavicz L.

J Clin Pathol. 2018 Feb;71(2):135-140. doi: 10.1136/jclinpath-2016-204302. Epub 2017 Jul 26.

PMID:
28747392
25.

A cell line thought to represent mucinous breast cancer probably represents lobular carcinoma with extracellular mucin production.

Cserni G.

Virchows Arch. 2017 Sep;471(3):433-434. doi: 10.1007/s00428-017-2195-y. Epub 2017 Jul 12. No abstract available.

PMID:
28702777
26.

[Five-year experience with the multidisciplinary evaluation of breast lesions according to the Decker radio-pathologic correlation system].

Cserni G, Ambrózay É, Serfőző O.

Orv Hetil. 2017 Jul;158(28):1100-1108. doi: 10.1556/650.2017.30790. Hungarian.

PMID:
28691880
27.

[Sudden cardiac death due to sarcoidosis. Case report].

Sejben I, Som Z, Cserni G.

Orv Hetil. 2017 Jul;158(27):1067-1070. doi: 10.1556/650.2017.30724. Hungarian.

PMID:
28670989
28.

Prognostic impact of macrometastasis linear size in sentinel node biopsy for breast carcinoma.

Foschini MP, Miglio R, Quinn C, Belgio B, Regitnig P, Bianchi S, Nannini R, Buerger H, Kaya H, Illyés I, Kulka J, Wells CA, De Gaetano J, Lipeniece-Karele I, Cserni G.

Eur J Surg Oncol. 2017 Aug;43(8):1421-1427. doi: 10.1016/j.ejso.2017.05.007. Epub 2017 May 17.

PMID:
28576464
29.

Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.

Cserni G, Floris G, Koufopoulos N, Kovács A, Nonni A, Regitnig P, Stahls A, Varga Z.

Virchows Arch. 2017 Jul;471(1):3-12. doi: 10.1007/s00428-017-2147-6. Epub 2017 May 20.

PMID:
28528509
30.

Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.

Zombori T, Cserni G.

Pathol Oncol Res. 2018 Apr;24(2):259-267. doi: 10.1007/s12253-017-0246-y. Epub 2017 May 3.

PMID:
28470571
31.

The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.

Kővári B, Vranic S, Marchio C, Sapino A, Cserni G.

Hum Pathol. 2017 Jun;64:164-170. doi: 10.1016/j.humpath.2017.03.026. Epub 2017 Apr 21.

32.

Solid Papillary Breast Carcinomas Resembling the Tall Cell Variant of Papillary Thyroid Neoplasms: A Unique Invasive Tumor With Indolent Behavior.

Foschini MP, Asioli S, Foreid S, Cserni G, Ellis IO, Eusebi V, Rosai J.

Am J Surg Pathol. 2017 Jul;41(7):887-895. doi: 10.1097/PAS.0000000000000853.

PMID:
28418993
33.

Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?

Cserni G, Zombori T, Andreu X, Bianchi S, Regitnig P, Amendoeira I, Balmativola D, Kovács A, Cordoba A, Reiner A, Kulka J, Kaya H, Liepniece-Karele I, Quinn C, Kővári B.

Pathol Oncol Res. 2018 Jan;24(1):167-170. doi: 10.1007/s12253-017-0229-z. Epub 2017 Apr 8.

PMID:
28391512
34.

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.

Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL, Kanthan R, Litwiniuk M, Di Benedetto A, Mottolese M, Provenzano E, Shousha S, Stephens M, Kulka J, Ellis IO, Titloye AN, Hanby AM, Shaaban AM, Speirs V.

Sci Rep. 2017 Mar 28;7:45293. doi: 10.1038/srep45293.

35.

Levél az emlőrák felismerésétől az emlőrákos betegek rehabilitációjáig tartó folyamat javításának érdekében.

A III. Emlőrák Konszenzuskonferencia munkacsoportjainak és szervezőbizottságának vezetői:, Forrai G, Lázár G, Cserni G, Polgár C, Horváth Z, Kahán Z, Kásler M, Svébis M.

Magy Seb. 2016 Dec;69(4):203-207. Hungarian. No abstract available.

PMID:
27991026
36.

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.

Humphries MP, Sundara Rajan S, Droop A, Suleman CAB, Carbone C, Nilsson C, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL, Kanthan R, Litwiniuk M, Di Benedetto A, Mottolese M, Provenzano E, Shousha S, Stephens M, Walker RA, Kulka J, Ellis IO, Jeffery M, Thygesen HH, Cappelletti V, Daidone MG, Hedenfalk IA, Fjällskog ML, Melisi D, Stead LF, Shaaban AM, Speirs V.

Clin Cancer Res. 2017 May 15;23(10):2575-2583. doi: 10.1158/1078-0432.CCR-16-1952. Epub 2016 Dec 16.

37.

[Pathological diagnosis, work-up and reporting of breast cancer. Recommendations of the 3rd Hungarian Consensus Conference on Breast Cancer].

Cserni G, Kulka J, Francz M, Járay B, Kálmán E, Kovács I, Krenács T, Udvarhelyi N, Vass L.

Magy Onkol. 2016 Sep;60(3):209-28. Epub 2016 Jun 20. Review. Hungarian.

38.

High-dose Radiation Induced Heart Damage in a Rat Model.

Kiscsatári L, Sárközy M, Kővári B, Varga Z, Gömöri K, Morvay N, Leprán I, Hegyesi H, Fábián G, Cserni B, Cserni G, Csont T, Kahán Z.

In Vivo. 2016 09-10;30(5):623-31.

PMID:
27566082
39.

[Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].

Cserni G.

Magy Seb. 2016 Mar;69(1):4-13. doi: 10.1556/1046.69.2016.1.2. Hungarian.

PMID:
26901689
40.

Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

Cserni G, Wells CA, Kaya H, Regitnig P, Sapino A, Floris G, Decker T, Foschini MP, van Diest PJ, Grabau D, Reiner A, DeGaetano J, Chmielik E, Cordoba A, Andreu X, Zolota V, Charafe-Jauffret E, Ryska A, Varga Z, Weingertner N, Bellocq JP, Liepniece-Karele I, Callagy G, Kulka J, Bürger H, Figueiredo P, Wesseling J, Amendoeira I, Faverly D, Quinn CM, Bianchi S.

Virchows Arch. 2016 Apr;468(4):473-81. doi: 10.1007/s00428-016-1909-x. Epub 2016 Jan 27.

PMID:
26818833
41.

The Petersen prognostic index revisited in Dukes B colon cancer--Inter-institutional differences.

Cserni G, Bori R, Sejben I, Ágoston EI, Ács B, Szász AM.

Pathol Res Pract. 2016 Feb;212(2):73-6. doi: 10.1016/j.prp.2015.08.006. Epub 2015 Sep 4.

PMID:
26724146
42.

Elastic staining does not assist detection of venous invasion in cutaneous melanoma.

Sejben I, Kocsis L, Török L, Cserni G.

Pathol Res Pract. 2016 Jan;212(1):51-3. doi: 10.1016/j.prp.2015.11.011. Epub 2015 Nov 14.

PMID:
26639870
43.

CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.

Kővári B, Báthori Á, Cserni G.

Pathobiology. 2015;82(6):259-63. doi: 10.1159/000440664. Epub 2015 Oct 20.

44.

Methylation biomarkers for pleomorphic lobular breast cancer - a short report.

Moelans CB, Vlug EJ, Ercan C, Bult P, Buerger H, Cserni G, van Diest PJ, Derksen PW.

Cell Oncol (Dordr). 2015 Oct;38(5):397-405. doi: 10.1007/s13402-015-0241-9. Epub 2015 Sep 21.

45.

Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.

Kővári B, Szász AM, Kulka J, Marušić Z, Šarčević B, Tiszlavicz L, Cserni G.

Pathobiology. 2015 Sep;82(3-4):166-71. doi: 10.1159/000375127. Epub 2015 Aug 31.

46.

Incidentally discovered diffuse large B-cell lymphoma limited to the endocervical mucosa in a young female patient.

Pósfai É, Nagy K, Marton I, Bánfalvi A, Kocsis L, Cserni G.

Gynecol Obstet Invest. 2015;80(2):134-8. doi: 10.1159/000369388. Epub 2015 Apr 14.

PMID:
25870905
47.

Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.

Cserni G, Maráz R.

Pathol Oncol Res. 2015 Sep;21(4):861-6. doi: 10.1007/s12253-015-9899-6. Epub 2015 Feb 4.

PMID:
25648437
48.

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.

Balmativola D, Marchiò C, Maule M, Chiusa L, Annaratone L, Maletta F, Montemurro F, Kulka J, Figueiredo P, Varga Z, Liepniece-Karele I, Cserni G, Arkoumani E, Amendoeira I, Callagy G, Reiner-Concin A, Cordoba A, Bianchi S, Decker T, Gläser D, Focke C, van Diest P, Grabau D, Lips E, Wesseling J, Arisio R, Medico E, Wells C, Sapino A.

Breast Cancer Res Treat. 2014 Dec;148(3):511-23. doi: 10.1007/s10549-014-3192-3. Epub 2014 Nov 14.

49.

Retrospective health-care associated infection surveillance in oral and maxillofacial reconstructive microsurgery.

Patyi M, Sejben I, Cserni G, Sántha B, Gaál Z, Pongrácz J, Oberna F.

Acta Microbiol Immunol Hung. 2014 Dec;61(4):407-16. doi: 10.1556/AMicr.61.2014.001.

PMID:
25361526
50.

Supplemental Content

Loading ...
Support Center